Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by luvhorseson Jul 15, 2020 10:29pm
140 Views
Post# 31273999

Long story short...it's going to take time for results from

Long story short...it's going to take time for results fromthe trials....so to make it easier to explain...just imagine that AGN was a gold company and they were drilling (re: Agn's human trials)...it would take some time for the drilling...just like how it would take time for the human trials to start.  After drilling, they need to send their results to the lab and as you all know, this takes time.  Same thing with the human trials..the results are sent to the labs and are analyzed...this takes time.

Long story short, just like for any gold company, results will take 6 - 8 weeks before they are released...so, for the human trials, results will take 6 -  8 weeks.
 So, back to  the AGN story, you're looking at Sept/Oct for the release of the human trial results....by then, this puppy will be in the .10 - .11, which is when I'll come back and buy a $hit load of them!!
<< Previous
Bullboard Posts
Next >>